This Mid-Cap Healthcare Stock, engaged in manufacturing condoms, personal lubricants, IVD kits, Consumer Healthcare and FMCG products, serving domestic markets and exporting to 125 countries globally, jumped 7.05 percent after the company raised its FY27 revenue and profit guidance. With expanding consumer distribution, new manufacturing capacity and international expansion, investors are watching whether Cupid’s two-business model can support its ambitious FY29 growth targets.
With a market capitalization of Rs. 36,904.21 crores, the share of Cupid Limited has reached an intraday high of Rs. 276.25 per equity share, rising nearly 7.05 percent from its previous day’s close price of Rs. 258.05. Since then, the stock has retreated and is currently trading at Rs. 274.45 per equity share.
Cupid Raises FY27 Revenue and Profit Targets
Cupid has raised its FY27 guidance, reflecting strong confidence in its future growth. The company expects revenue of Rs. 725-750 crore, compared with Rs. 358 crore in FY26, representing growth of around 103-109 percent.
The company is also targeting a net profit of Rs. 210-225 crore, compared with Rs. 108 crore in FY26, indicating profit growth of around 94-108 percent. This guidance highlights the company’s expectations of strong business performance and improving profitability.
Also Read: Tribhovandas Bhimji Zaveri Stock Up Over 300% in 2026: What Changed for the Jewellery Retailer?
Medium-Term Revenue Targets
Cupid has set strong revenue targets for the coming years. It aims to reach Rs. 1,085 crore in FY28 and Rs. 1,500 crore in FY29, compared with Rs. 358 crore in FY26. This represents revenue growth of around 203 percent by FY28 and 319 percent by FY29, showing a significant expansion in the company’s business.
The company’s revenue is expected to grow at a CAGR of approximately 61 percent from FY26 to FY29. These targets reflect Cupid’s plans to expand its business across both domestic and international markets and achieve strong, sustained growth.
The growth will be supported by a wider distribution network across Bharat, higher sales of consumer products, and new manufacturing capacity. Cupid also expects opportunities from global tenders and plans to expand its international manufacturing and healthcare operations.
Expanding Consumer Distribution
Cupid is expanding its consumer distribution network through a Rs. 331.53 crore investment in Baazar Style Retail. This partnership gives Cupid access to more than 280 stores, with the network expected to grow to over 500 stores in the next two to three years. The wider retail presence is expected to improve product availability and help the company reach more consumers across India.
The initiative is expected to contribute around Rs. 150 crore in revenue in FY27, with the potential to scale to nearly Rs. 500 crore annually in the coming years. Cupid is also strengthening its brand positioning through its “Made in India with Japanese Quality” initiative, supported by a collaboration with one of Asia’s oldest condom manufacturers, combining local manufacturing with Japanese quality standards.
Expanding Capacity and Global Markets
Cupid is expanding its manufacturing capabilities by developing nitrile products, including a premium, latex-free nitrile female condom for the global market. Its dual-polymer production lines at Palava will enable the company to manufacture both latex and nitrile condoms in India. The 170,000 sq. ft. Palava facility is expected to be commissioned in the next quarter and represents Cupid’s largest manufacturing investment.
Once fully operational, the facility is expected to support annual capacity of approximately 1.25 billion male condoms and 125 million female condoms. Cupid has also received CE certification under the European IVDR for its HIV, Hepatitis B, Syphilis and pregnancy test kits. This certification can support the company’s entry into European markets and global public-health screening programmes.
Two Growth Engines Supporting The Business
Cupid’s business is supported by two complementary growth engines: its global healthcare business and its Bharat consumer business. The global healthcare segment serves national health programmes, multilateral agencies and brand owners across international markets, providing the company with a strong international presence.
Cupid is the first company in the world to receive WHO/UNFPA pre-qualification for both male and female condoms. In FY26, exports reached Rs. 208 crore, contributing nearly 60 percent of total revenue across more than 125 countries. The company also reported its strongest order pipeline, supporting future growth.
The consumer business includes condoms, personal lubricants, Consumer Healthcare and FMCG products. It contributed approximately Rs. 122 crore in FY26, including Rs. 84 crore from recently launched FMCG products. Cupid’s strategy is increasingly focused on combining its established global healthcare leadership with the growing consumer opportunity in Bharat.
Strategic Expansion After FY26
After FY26, Cupid announced two important strategic developments to support its international expansion. In July 2026, the company made an additional USD 5 million investment in GII Healthcare Investment Limited, funded entirely through internal accruals. This investment strengthens Cupid’s relationship with the platform and provides greater exposure to the growing GCC healthcare market, including opportunities in Saudi Arabia.
In August 2026, Cupid’s Board gave in-principle approval for a proposed manufacturing venture in South Africa with a local partner. Under the proposed structure, Cupid is expected to hold up to 49 percent, while the local partner and/or qualifying shareholders would hold at least 51 percent. This structure is designed to support local participation while limiting Cupid’s capital requirements.
The proposed asset-light model would allow Cupid to contribute manufacturing expertise, technology, quality systems and training, while the local partner funds the facility and operations. The venture could strengthen Cupid’s presence in South Africa and create a platform for wider expansion across Africa and other international markets, subject to approvals.
Can Cupid’s Two-Business Model Deliver Strong Growth?
Cupid Limited’s two-business model provides multiple avenues for growth through its global healthcare and Bharat consumer businesses. The global segment has a presence in more than 125 countries, with FY26 exports of Rs. 208 crore, while the consumer business contributed around Rs. 122 crore. At the same time, expanding retail distribution, new FMCG products and the Palava facility could support domestic growth and increase production capacity.
International expansion also adds potential growth opportunities through the GCC investment and proposed South African manufacturing venture. With greater consumer reach, higher manufacturing capabilities and expansion into new markets, Cupid has several growth drivers across both businesses, although execution and market demand will remain important factors.
Also Read: Can Divi’s Laboratories Custom Synthesis Continue Delivering Growth
Company Overview
Cupid Limited was established in 1993 and is a leading healthcare and consumer wellness company focused on male and female condoms, personal lubricants, IVD kits and Consumer Healthcare & FMCG products. The company has a strong international presence, exporting to more than 125 countries and serving government, institutional and private markets.
Cupid is the first company globally to receive WHO/UNFPA prequalification for both male and female condoms. In India, the company is expanding its presence across modern trade, organised retail and pharmacy channels. Its upcoming Palava facility will further strengthen manufacturing capacity and support growing domestic and international demand.
Recent Quarter Results
Looking at the company’s financial highlights, Cupid Limited’s revenue has increased from Rs. 65 crore in Q1 FY26 to Rs. 157 crore in Q1 FY27, which has grown by 141.54 percent. The net profit has also grown by 193.33 percent from Rs. 15 crore in Q1 FY26 to Rs. 44 crore in Q1 FY27.
Cupid Limited’s revenue and net profit have grown at a CAGR of 20 percent and 31 percent, respectively, over the last five years. In terms of return ratios, the company’s ROCE and ROE stand at 33.9 percent and 27.6 percent, respectively. Cupid Limited has an earnings per share (EPS) of Rs. 1.02, and its debt-to-equity ratio is 0.13x.